The COVID-19 crisis brought critical care medicine into the global spotlight and re-exposed systemic gaps in patient care. Four years after the initial surge of cases, the Max Harry Weil Institute for Critical Care Research and Innovation at the University of Michigan is asking the question: where do we go from here?
Read MoreUniversity of Michigan researchers examine if molecular compounds in exhaled breath could lead to improved diagnosis and tracking of acute respiratory distress syndrome (ARDS).
Read MorePortable Gas Chromatography Device and Body Odor Sensor for Disease Detection were featured in the Department of Biomedical Engineering’s annual Innovations magazine.
Read MoreResearchers examine if breath exhaled after injury could provide a potential pathway to non-invasive, point-of-care monitoring.
Read MoreA recent study by Weil Institute investigators was featured on the Michigan Medicine Health Lab blog.
Read MoreResearch published by Weil Institute investigators in JAMA Network Open suggests volatile organic compounds in breath could mark distinction between COVID-19, variants and non-COVID illnesses.
Read MoreDr. Xudong (Sherman) Fan has been appointed the University of Michigan Richard A. Auhll Endowed Professor of Engineering. The role will be made official during a recognition ceremony on January 27.
Read MoreA research team led by Weil Institute Associate Director Xudong (Sherman) Fan, PhD has received a $5.7 million grant from the NIH SCENT program to develop a portable sensor that uses body odor to detect over 20 acute and chronic, inflammatory, metabolic, respiratory, cardiovascular and skin diseases in both adults and children.
Read More
